Loading…
Saturday, September 20, 2014
Current Weather
Loading Current Weather....
HomeNewsMedical
Published: Thursday, 4/7/2005

<font face='verdana' size='1' color =#CC0000><b> * New * </b></font> FDA asks Pfizer to take Bextra off market

ASSOCIATED PRESS

WASHINGTON The government said today it has asked Pfizer Inc. to withdraw the painkiller Bextra from the market because it increases the risk of heart attack and stroke. Regulators also want all other anti-inflammatory drugs in the same class to carry the strongest safety warning possible.

The Food and Drug Administration has been studying the safety of the so-called Cox-2 inhibiters since Merck & Co. voluntarily pulled Vioxx from the market Sept. 30 after heart problems were reported in some users.

In addition to the prescription drugs, the FDA asked manufacturers of over-the-counter nonsteroidal anti-inflammatory drugs to revise their labels to include information about the risks of cardiovascular incident and gastrointestinal bleeding.

Read more in later editions of The Blade and toledoblade.com.



Guidelines: Please keep your comments smart and civil. Don't attack other readers personally, and keep your language decent. If a comment violates these standards or our privacy statement or visitor's agreement, click the "X" in the upper right corner of the comment box to report abuse. To post comments, you must be a Facebook member. To find out more, please visit the FAQ.